Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
Doyle
Tracy L
TL
IWKHealth Center, Halifax, Nova Scotia, Canada; Dalhousie University, Halifax, Canada. tldoyle@dal.ca
Casas
Michael J
MJ
Kenny
David J
DJ
Judd
Peter L
PL
D017607:Aluminum Compounds / Q000627:therapeutic use*; D000704:Analysis of Variance; D017610:Calcium Compounds / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D002648:Child; D003738:Dental Cements / Q000627:therapeutic use*; D003785:Dental Pulp Capping / Q000379:methods; D004338:Drug Combinations; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use; D006801:Humans; D053208:Kaplan-Meier Estimate; D016015:Logistic Models; D008297:Male; D008963:Molar; D010087:Oxides / Q000627:therapeutic use*; D011446:Prospective Studies; D011672:Pulpotomy / Q000379:methods*; D017640:Silicates / Q000627:therapeutic use*; D014094:Tooth, Deciduous; D016896:Treatment Outcome
D017607:Aluminum Compounds; D017610:Calcium Compounds; D003738:Dental Cements; D004338:Drug Combinations; D005290:Ferric Compounds; D010087:Oxides; D017640:Silicates; C086631:mineral trioxide aggregate; C024823:ferric sulfate